Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI).
about
EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guideCharacterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvementsDevelopment of the Sjögren's Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacy.Epidemiology of neurological manifestations in Sjögren's syndrome: data from the French ASSESS Cohort.Characterization and risk estimate of cancer in patients with primary Sjögren syndromeThe Diagnosis and Treatment of Sjögren's Syndrome.Severe Health-Related Quality of Life Impairment in Active Primary Sjögren's Syndrome and Patient-Reported Outcomes: Data From a Large Therapeutic Trial.Subjective and Objective Measures of Dryness Symptoms in Primary Sjögren's Syndrome - Capturing the discrepancy.It's more than dryness and fatigue: The patient perspective on health-related quality of life in Primary Sjögren's Syndrome - A qualitative studyOverlap between differentially methylated DNA regions in blood B lymphocytes and genetic at-risk loci in primary Sjögren's syndromeA phase II investigator-initiated pilot study with low-dose cyclosporine A for the treatment of articular involvement in primary Sjögren's syndrome.Incidence and Mortality of Physician-Diagnosed Primary Sjögren Syndrome: Time Trends Over a 40-Year Period in a Population-Based US Cohort.Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.Effectiveness of Traditional Chinese Medicine Compound JieDuTongLuoShengJin Granules Treatment in Primary Sjögren's Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.Combined interventional sialendoscopy and intraductal steroid therapy for recurrent sialadenitis in Sjögren's syndrome: Results of a pilot monocentric trial.Treating the Underlying Pathophysiology of Primary Sjögren Syndrome: Recent Advances and Future Prospects.Primary Sjögren's syndrome: clinical phenotypes, outcome and the development of biomarkers.Clinical relevance of RORγ positive and negative subsets of CD161+CD4+ T cells in primary Sjögren's syndrome.Development of the ClinESSDAI: a clinical score without biological domain. A tool for biological studies.Towards personalised treatment in primary Sjögren's syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment.Cryoglobulinaemic vasculitis at diagnosis predicts mortality in primary Sjögren syndrome: analysis of 515 patients.Clinical predictors of silent but substantial liver fibrosis in primary Sjogren's syndrome.Hypokalemic Paralysis: A Hidden Card of Several Autoimmune DiseasesPatient burden of Sjögren's: a comprehensive literature review revealing the range and heterogeneity of measures used in assessments of severity.Deregulation of microRNA expression in purified T and B lymphocytes from patients with primary Sjögren's syndrome.A qualitative exploration of physical, mental and ocular fatigue in patients with primary Sjögren's Syndrome.Comparison of 2002 AECG and 2016 ACR/EULAR classification criteria and added value of salivary gland ultrasonography in a patient cohort with suspected primary Sjögren's syndrome.Systematic review of randomized controlled trials in the treatment of dry eye disease in Sjogren syndrome.Fatigue in Primary Sjögren's Syndrome: Clinical, Laboratory, Psychometric, and Biologic Associations.Systemic activity and mortality in primary Sjögren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients.Evaluation and treatment of Sjögren's syndrome in focus.Factors associated with severe dry eye in primary Sjögren's syndrome diagnosed patients.How to Distinguish Patients with pSS among Individuals with Dryness without Invasive Diagnostic Studies.Do the European League Against Rheumatism (EULAR) Sjögren's syndrome outcome measures correlate with impaired quality of life, fatigue, anxiety and depression in primary Sjögren's syndrome?Sjögren syndrome
P2860
Q26778262-2CF813C5-2007-44D9-B6A0-10CBF50FE158Q26800693-C890CE29-8950-445E-BE51-CB3039899CA7Q30948155-1BD0F345-18FE-4870-B355-326F9E19FE74Q31083973-CE206D09-BE90-4657-B7A3-DE0959AA0F30Q33568158-F83B2357-EDF8-4763-95A4-173094C59300Q33800932-860D0A69-D591-4DC4-84BF-F41739CBD0CAQ36070691-C3AA72DA-DC2C-4352-AE0C-9A1A7B7DE01EQ36228694-0E3B228C-837F-4662-85D5-C71899A5AB97Q36275817-33C826CD-A5A6-4BED-AD40-AB7DDE0D2476Q36859599-1C49CD1B-0099-4C6C-8BF3-8A9E47AA0493Q38389487-0C9333B0-D759-436D-AF92-FBDB60B7E57FQ38401667-29784879-45EA-4E0E-957B-8FF0410D5FEAQ38561490-FE349C36-A78B-44D1-8CB7-2DA284A0130AQ38645543-51EF33A2-CF14-4F39-A9C8-557AF73498F9Q38741479-61425FBE-0373-469A-838E-2D355922B760Q38795404-C26EE702-7FFB-4D94-B6DF-1EB57F2C1EBBQ38905170-0BA0D826-2F0C-4C92-B04D-3DBC42E38CF1Q39226046-925EE1E2-8885-49B8-99A0-65507061ADBBQ39791068-B4B6C571-6BF3-41C8-B0EF-66717FDB31D4Q40117123-2CFA1E89-CD5F-4B7D-81FC-78DDE16044FEQ40785165-18DCFEBD-3AC6-4CBF-83AD-0A1F0D9A7D98Q41110444-8AEB2903-9CAB-4D61-98BA-0573008DF3BBQ41281885-78E24A15-2ABE-4943-B893-9DC9C9DF549DQ41687111-2E4ADA61-505E-4CB6-A893-68ACC5A44DD8Q41936370-CBA4C50A-C78A-4F96-9C08-C80B176E6216Q46207185-2991A39D-5F80-45A2-98CC-EA9FD061AF81Q47100479-0E274494-6028-4285-AB98-7A646CB2DE0FQ47133516-30B624A0-64E7-4E8C-994F-C0A03E2BBBECQ47942672-822B7C12-C09B-46F9-974C-134D85D6595AQ48249597-450E3D19-7950-4BFF-BE43-BB710DD32DCCQ54492412-ECE4E508-1FCC-463A-A8DF-0830D2C952AFQ55174890-09D2A365-C917-4ED8-BF6B-A55825FE200CQ55283251-A9C10DA0-76D9-4A4D-A82B-DA63792A2532Q55633625-A70EA6DA-5677-4F19-9F9E-E041E5924749Q55970262-09329F7A-C777-44FA-AFCD-1428E3312322
P2860
Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI).
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Validation of EULAR primary Sj ...... and patient indexes (ESSPRI).
@en
Validation of EULAR primary Sjögren's syndrome disease activity
@nl
type
label
Validation of EULAR primary Sj ...... and patient indexes (ESSPRI).
@en
Validation of EULAR primary Sjögren's syndrome disease activity
@nl
prefLabel
Validation of EULAR primary Sj ...... and patient indexes (ESSPRI).
@en
Validation of EULAR primary Sjögren's syndrome disease activity
@nl
P2093
P2860
P50
P1476
Validation of EULAR primary Sj ...... and patient indexes (ESSPRI).
@en
P2093
Aike A Kruize
Anne-Laure Fauchais
Athanasios Tzioufas
Claudio Vitali
Cristina Vollenweider
EULAR Sjögren's Task Force
Elke Theander
Hendrika Bootsma
Jacques-Eric Gottenberg
Johan G Brun
P2860
P304
P356
10.1136/ANNRHEUMDIS-2013-204615
P407
P50
P577
2014-01-17T00:00:00Z